Keros Therapeutics (KROS) Revenue (QoQ) (2019 - 2025)

Keros Therapeutics (KROS) Revenue (QoQ) (2019 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 69,146.49 Bn 69,146.20 Bn -
2 Nanobiotix 1,942.19 Bn 1,942.13 Bn -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn -
4 BeOne Medicines 475.42 Bn 470.63 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.32 Bn 116.08 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.80 Bn 61.04 Bn 3.31 Bn
7 Belite Bio 63.28 Bn 63.28 Bn -
8 Argenx Se 56.67 Bn 51.48 Bn 1.41 Bn
9 Revolution Medicines 38.15 Bn 38.15 Bn -
10 Keros Therapeutics 390.45 Mn 103.05 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -98.67%
Sep 30, 2025 -22.26%
Jun 30, 2025 -91.40%
Mar 31, 2025 6,844.31%
Dec 31, 2024 684.02%
Mar 31, 2024 -41.96%
Dec 31, 2023 1,687.50%
Mar 31, 2022 0.56%
Dec 31, 2019 0.00%
Sep 30, 2019 0.00%
Jun 30, 2019 0.00%